Month 2014
Tetraindanotetraoxa[8]circulenes
4,7-Dimethoxyindane (4a).
A solution of 5a (3.46 g;
4,7-Dimethoxyindane-1-one (5a). A mixture of 6 (20.0 g;
71.0 mmol), dimethylformamide (DMF, two drops), and SOCl2
(20.40 g; 12.43 mL; 171.0 mmol) was refluxed for 5 h and
cooled on an ice bath. CH2Cl2 (200 mL) was added and the
mixture cooled to -5 to -10 °C. AlCl3 (25.23 g; 0.19 mol) was
added over a period of 45 min under vigorous stirring, and the
reaction was stirred for an additional 5 min. The reaction
mixture was poured into ice water (300 mL) and stirred
vigorously for 10 min. The two phases were separated, and the
organic phase was washed with H2O (100 mL) followed by
vigorous stirring with saturated NaHCO3(aq) (3 × 150 mL,
10 min each). The organic phase was dried (MgSO4) and
filtered, and the volatile components were removed under
reduced pressure to give a yellow solid material. After a few
hours on a vacuum line, the product was mechanically crushed
and stirred in Et2O (80 mL) for 1.5 h. The product was collected
on a glass filter funnel with suction and dried under reduced
pressure overnight to give 13.1 g (72%) of the product as a pale
yellow powder, mp 122–123 °C. Lit.: 124.5–125 °C (Et2O) [18].
1H NMR (CDCl3, 300 MHz): δ 6.98 (d, J = 8.7 Hz, 1H), 6.73 (d,
J = 8.7 Hz, 1H), 3.90 (s, 3H), 3.85 (s, 3H), 2.98 (t, J = 6.0 Hz,
2H), 2.67 (t, J = 6.0 Hz, 2H). 13C NMR (CDCl3, 75 MHz): δ
205.2, 151.9, 150.6, 146.1, 126.5, 116.7, 109.5, 56.1, 56.0,
36.9, 22.4. MS (m/z, int.): 192 (100), 177 (25), 163 (99), 149
(36) 121 (30).
4,7-Dimethoxy-2,2-dimethylindane-1-one (5b). To a solution
of 6 (5.1 g; 26.5 mmol) in THF (130mL) was added under stirring
NaH (1.7g; ~63.8 mmol) and then MeI (8.9 g; 3.9 mL;
62.7mmol), and it was stirred for about 5 h. The reaction mixture
was poured into H2O (300 mL), and the mixture was made
weakly acidic by an addition of HCl(aq) (2M). The product was
extracted with Et2O/THF (1:1; 100 mL) and then with Et2O
(3× 100 mL). The combined organic phases were washed with
saturated NaHCO3(aq), dried (MgSO4), and concentrated under
reduced pressure to give an orange to brown crude product. The
crude product was purified using a dry column (eluting from
heptane with EtOAc; 10%) to give 3.8g (65%) of the desired
product as yellow crystals, mp 69–70°C. 1H NMR (CDCl3,
300 MHz): δ 6.99 (d, J = 8.7 Hz, 1H), 6.73 (d, J = 8.7Hz, 1H),
3.90 (s, 3H), 3.84 (s, 3H), 2.86 (s, 2H), 1.21 (s, 6H). 13C NMR
(CDCl3, 75MHz): δ 209.5, 152.3, 150.6, 142.9, 124.6, 116.7,
109.6, 56.1, 55.9, 45.6, 39.3, 25.6. MS (m/z, int.): 220 (95), 205
(100), 187 (64), 175 (23). Anal. Calcd. for C13H16O3: C, 70.89;
H, 7.32. Found: C, 70.86; H, 7.30.
18.0 mmol), Pd-C (1.38 g; 10% Pd on carbon) and HClO4
(1.1 mL; 70% in H2O) in HOAc (50 mL) was treated with H2 at
55 psi (H2) for 2.5 h. The reaction mixture was then treated with
NaOAc(s) (1.45 g; 18.0 mmol) to remove HClO4. The mixture
was filtered through a plug of celite with suction. The filtrate
was added H2O (300 mL), and the product was extracted with
CHCl3 (3 × 70 mL). The combined organic phases were washed
with H2O (200 mL), dried (MgSO4), and concentrated under
reduced pressure to yield 2.8 g (87%) of the product as a
white solid material, mp 78–80 °C. Lit.: 65–66 °C (Et2O) [15],
85–85.5 °C [18]. 1H NMR (CDCl3, 300 MHz): δ 6.61 (s, 2H),
3.79 (s, 6H), 2.88 (t, 4H), 2.13–2.03 (m, 2H). 13C NMR
(CDCl3, 75 MHz): δ 150.5, 133.9, 108.7, 55.8, 30.1, 24.9. MS
(m/z, int.): 178 (92), 163 (100), 103 (29), 91 (20).
4,7-Dimethoxy-2,2-dimethylindane (4b).
was synthesized from 5b using the procedure described for 4a.
The yield for this procedure was 1.8 g (88%) of the product as a
white solid material, mp 54–56°C. H NMR (CDCl3, 300MHz):
This compound
1
δ 6.61 (s, 2H), 3.78 (s, 6H), 2.70 (s, 4H), 1.16 (s, 6H). 13C NMR
(CDCl3, 75 MHz): δ 150.7, 132.9, 108.6, 55.8, 44.9, 40.0, 29.5.
MS (m/z, int.): 206 (100), 191 (53), 176 (11), 161 (12). Anal.
Calcd. for C13H18O2: C, 75.69; H, 8.80. Found: C, 75.76; H, 8.91.
2,2-Diethyl-4,7-dimethoxyindane (4c). This compound was
synthesized from 5c using the procedure described for 4a. The
yield for this procedure was 0.7 g (88%) of the product as a white
solid material, mp 38–40 °C. 1H NMR (CDCl3, 300MHz): δ 6.60
(s, 2H), 3.78 (s, 6H), 2.69 (s, 4H), 1.49 (q, J = 7.5 Hz, 4H), 0.85
(t, J = 7.5 Hz, 6H). 13C NMR (CDCl3, 75 MHz): δ 150.5, 132.8,
108.4, 55.8, 46.3, 41.0, 31.2, 9.1. MS (m/z, int.): 234 (100), 205
(25), 175 (13), 149 (17), 91 (16). Anal. Calcd. for C15H22O2: C,
76.88; H, 9.46. Found: C, 77.20; H, 9.69.
2,2-Dibutyl-4,7-dimethoxyindane (4d).
This compound
was synthesized from 5d using the procedure described for 4a
(hydrogenation was complete after 4 h). The yield for this
procedure was 6.8 g (87%) of the product as a clear, almost
1
colorless oil. H NMR (CDCl3, 300 MHz): δ 6.61 (s, 2H), 3.79
(s, 6H), 2.73 (s, 4H), 1.48–1.43 (m, 4H), 1.33–1.24 (m, 8H),
0.91 (t, 6H). 13C NMR (CDCl3, 75 MHz): δ 150.4, 132.7,
108.4, 55.7, 45.6, 41.9, 39.3, 27.1, 23.7, 14.3. MS (m/z, int.):
290 (100), 191 (11), 177 (34), 152 (13). Anal. Calcd. for
C19H30O2: C, 78.57; H, 10.41. Found: C, 78.34; H, 10.66.
2,2-Dihexyl-4,7-dimethoxyindane (4e).
was synthesized from 5e using the procedure described for 4a
This compound
(hydrogenation was complete after 4.5 h). The yield for this
procedure was 1.5 g (81%) of the product as a yellowish oil. H
2,2-Diethyl-4,7-dimethoxyindane-1-one (5c). This compound
was synthesized by alkylation of 5a with EtI as described for 5b.
The yield of this procedure was 1.2 g (66%) of the product as a
yellow crystalline material, mp 75–76°C. 1H NMR (CDCl3,
300 MHz): δ 6.97 (d, J = 8.7 Hz, 1H), 6.71 (d, J = 8.7Hz, 1H),
3.89 (s, 3H), 3.86 (s, 3H), 2.83 (s, 2H), 1.73–1.52 (m, 4H), 0.78
(t, J = 7.5 Hz, 6H). 13C NMR (CDCl3, 75 MHz): δ 209.6, 151.7,
150.4, 144.2, 126.7, 116.5, 109.4, 56.1, 55.9, 53.5, 33.2, 30.0,
8.8. MS (m/z, int.): 248 (66), 219 (100), 205 (88), 191 (54). Anal.
Calcd. for C15H20O3: C, 72.55; H, 8.12. Found: C, 72.65; H, 8.22.
2,2-Dibutyl-4,7-dimethoxyindane-1-one (5d). This compound
was synthesized by alkylation of 6 with n-butyl iodide as described
for 4. The yield of this procedure was 9.1 g (64%) of the product as
a yellow crystalline material, mp. 71–72 °C. 1H NMR (CDCl3,
300 MHz): δ 6.97 (d, J = 8.7 Hz, 1H), 6.71 (d, J = 8.7 Hz, 1H),
3.89 (s, 3H), 3.86 (s, 3H), 2.85 (s, 2H), 1.66–1.48 (m, 4H),
1.27–1.02 (m, 8H), 0.82 (t, J = 7.2 Hz, 6H). 13C NMR (CDCl3,
75 MHz): δ 209.8, 151.7, 150.3, 144.2, 126.6, 116.5, 109.4,
1
NMR (CDCl3, 300 MHz): δ 6.60 (s, 2H), 3.78 (s, 6H), 2.70
(s, 4H), 1.45–1.40 (m, 4H), 1.31–1.25 (m, 16H), 0.87 (t, 6H).
13C NMR (CDCl3, 75 MHz): δ 150.4, 132.7, 108.4, 55.7, 45.8,
41.9, 39.6, 32.0, 30.3, 24.8, 22.9, 14.3. MS (m/z, int.): 346
(100), 189 (13), 177 (33), 152 (9). Anal. Calcd. for C23H38O2:
C, 79.71; H, 11.05. Found: C, 79.71; H, 11.05.
4,7-Dimethoxy-2,2-dioctylindane (4f). This compound was
synthesized from 5f using the procedure described for 4a
(hydrogenation of this compound was complete after 5 h). The
yield for this procedure was 2.4 g (84%) of the product as a
yellow oil. 1H NMR (CDCl3, 300 MHz): δ 6.60 (s, 2H), 3.78
(s, 6H), 2.70 (s, 4H), 1.42–1.25 (m, 28H), 0.88 (t, 6H). 13C
NMR (CDCl3, 75 MHz): δ 150.5, 132.8, 108.4, 55.8, 45.8, 41.9,
39.6, 32.1, 30.7, 29.8, 29.5, 24.8, 22.8, 14.3. MS (m/z, int.):
402 (100), 189 (14), 177 (37), 152 (10). Anal. Calcd. for
C27H46O2: C, 80.54; H, 11.51. Found: C, 80.81; H, 11.84.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet